Page 10 - Vaccine Administration Under Emergency Use Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women

Investegate announcements from BioNTech SE, Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women

New yorkUnited statesUnited kingdomSouth africaSylke maasWilliam gruberChuck trianoFosun pharmaJerica pittsInvasive groupb streptococcus infection phaseBayer animal healthPfizer incEuropean unionCenters for diseaseDrug administrationVaccine clinical research

BioNTech SE: Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women

Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina, Brazil, Chile, Mozambique, South Africa, U.K., and SpainFirst participants dosed in the U.S. Women

New yorkUnited statesUnited kingdomSouth africaSylke maasWilliam gruberChuck trianoFosun pharmaJerica pittsInvasive groupb streptococcus infection phaseBayer animal healthEuropean unionCenters for diseasePfizer inc nasdaqDrug administrationVaccine clinical research

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Press release content from Business Wire. The AP news staff was not involved in its creation. Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY® February 17, 2021 GMT NEW YORK & MAINZ, Germany (BUSINESS WIRE) Feb 17, 2021 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY ®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses. ADVERTISEMENT This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter.

United statesUnited kingdomSylke maasAlbert bourlaChuck trianoAndrew widgerUgur sahinFosun pharmaCenters for diseaseEuropean commissionDrug administrationBayer animal healthExchange commissionPfizer incEuropean unionRoche group

Pfizer and BioNTech to Supply European Union with 200 Million Additional Doses of COMIRNATY

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021 European Commission has the.

United statesUnited kingdomAlbert bourlaUgur sahinCenters for diseaseEuropean commissionDrug administrationPfizer incEuropean unionVaccine administration under emergency use authorizationChief executive officerMarketing authorizations holderEmergency use authorizationCoronavirus diseaseFact sheetHealthcare providers administering vaccine

BioNTech SE: In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations

BioNTech SE: In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomFree stateSouth africaSouth africanSylke maasChuck trianoFosun pharmaJerica pittsCenters for diseaseDrug administrationUniversity of texas medical branchBayer animal healthExchange commissionEuropean union